MultiPlan Corporation reported a decrease in revenue to $242.8 million, a net loss of $24.1 million, and an adjusted EBITDA of $152.3 million for Q3 2023. The company saw a decrease compared to the previous year, but is on track to deliver on its full-year 2023 guidance.
Q3 2023 revenues reached $242.8 million, reflecting a 3.1% decrease compared to Q3 2022.
The company reported a net loss of $24.1 million for Q3 2023, a shift from the $19.7 million net income in Q3 2022.
Adjusted EBITDA for Q3 2023 was $152.3 million, compared to $172.2 million in Q3 2022.
Potential medical cost savings identified were approximately $5.8 billion in Q3 2023, a 7% increase from Q3 2022.
The Company anticipates Q4 2023 revenues between $240 million and $250 million and Adjusted EBITDA between $155 million and $165 million.
Analyze how earnings announcements historically affect stock price performance